MAP3K1 and familial pancreatic carcinoma: Phosphoproteomic analyses following 51-106 treatment revealed that nucleophosmin (NPM1)T199 phosphorylation is decreased upon MAP3K1 inhibition and is associated with cell cycle regulation in pancreatic cancer cells.